Patents by Inventor Chris Parry

Chris Parry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12606521
    Abstract: Phenylsulfonamido compounds that inhibit genome-wide hypomethylation and can be used to treat cancer, including melanoma, prostate cancer, pancreatic cancer, breast cancer, colon cancer, lung cancer, ovarian cancer, and glioblastoma, are provided.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: April 21, 2026
    Assignee: Institute For Cancer Research
    Inventors: Alfonso Bellacosa, John Karanicolas, Timothy J. Yen, Michael Cory, Chris Parry, Rahul Prasad
  • Publication number: 20240190817
    Abstract: Phenylsulfonamido compounds that inhibit genome-wide hypomethylation and can be used to treat cancer, including melanoma, prostate cancer, pancreatic cancer, breast cancer, colon cancer, lung cancer, ovarian cancer, and glioblastoma, are provided.
    Type: Application
    Filed: August 30, 2021
    Publication date: June 13, 2024
    Inventors: Alfonso Bellacosa, John Karanicolas, Timothy J. Yen, Michael Cory, Chris Parry, Rahul Prasad